非酒精性脂肪性肝病与心血管疾病机制的研究进展
摘要
近年来,非酒精性脂肪性肝病(NAFLD)在世界范围内越来越受到关注,其定义为除酒精和其他明确的肝损伤因素所致的、以弥漫性肝细胞大泡性脂肪变为主要特征的临床病理综合征[1]。NAFLD为一系列进展性疾病谱,包括单纯性脂肪变、脂肪性肝炎、肝硬化[2],被认为是代谢综合征在肝脏的表现,同时与心血管疾病(C V D)也有密切关系[3]。关于NAFLD与CVD的相关性有许多流行病学报道,本文就N A F L D作为C V
参考文献7
-
1Masahide Hamaguchi,Takao Kojima,Noriyuki Takeda,Chisato Nagata,Jun Takeda,Hiroshi Sarui,Yutaka Kawahito,Naohisa Yoshida,Atsushi Suetsugu,Takahiro Kato,Junichi Okuda,Kazunori Ida,Toshikazu Yoshikawa.Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease[J].World Journal of Gastroenterology,2007,13(10):1579-1584. 被引量:56
-
2Naim Alkhouri,Tarek Abu-Rajab Tamimi,Lisa Yerian,Rocio Lopez,Nizar N. Zein,Ariel E. Feldstein.The Inflamed Liver and Atherosclerosis: A Link Between Histologic Severity of Nonalcoholic Fatty Liver Disease and Increased Cardiovascular Risk[J].Digestive Diseases and Sciences.2010(9)
-
3G. Targher,F. Marra,G. Marchesini.Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?[J].Diabetologia.2008(11)
-
4Anna Ludovica Fracanzani,Larry Burdick,Sara Raselli,Paola Pedotti,Liliana Grigore,Gennaro Santorelli,Luca Valenti,Alessandra Maraschi,Alberico Catapano,Silvia Fargion.Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease[J].The American Journal of Medicine.2008(1)
-
5G. Targher,L. Bertolini,S. Rodella,G. Zoppini,G. Lippi,C. Day,M. Muggeo.Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients[J].Diabetologia.2008(3)
-
6Jeremy P. Domanski,Stephen J. Park,Stephen A. Harrison.Cardiovascular Disease and Nonalcoholic Fatty Liver Disease: Does Histologic Severity Matter?[J].Journal of Clinical Gastroenterology.2012(5)
-
7Maria Stepanova,Zobair M. Younossi.Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population[J].Clinical Gastroenterology and Hepatology.2012(6)
二级参考文献29
-
1[1]Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology 2003; 37:1202-1219
-
2[2]Bellentani S,Saccoccio G,Masutti F,Croce LS,Brandi G,Sasso F,Cristanini G,Tiribelli C.Prevalence of and risk factors for hepatic steatosis in Northern Italy.Ann Intern Med 2000;132:112-117
-
3[3]Browning JD,Szczepaniak LS,Dobbins R,Nuremberg P,Morton JD,Cohen JC,Grundy SM,Hobbs HH.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity.Hepatology 2004; 40:1387-1395
-
4[4]Chitturi S,Farrell GC,George J.Non-alcoholic steatohepatitis in the Asia-Pacific region:future shock? J Gastroenterol Hepatol 2004; 19:368-374
-
5[5]Akbar DH,Kawther AH.Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic:prevalence and general characteristics.Diabetes Care 2003; 26:3351-3352
-
6[6]Gupte P,Amarapurkar D,Agal S,Baijal R,Kulshrestha P,Pramanik S,Patel N,Madan A,Amarapurkar A,Hafeezunnisa.Non-alcoholic steatohepatitis in type 2 diabetes mellitus.J Gastroenterol Hepatol 2004; 19:854-858
-
7[7]Assy N,Kaita K,Mymin D,Levy C,Rosser B,Minuk G.Fatty infiltration of liver in hyperlipidemic patients.Dig Dis Sci 2000; 45:1929-1934
-
8[8]Donati G,Stagni B,Piscaglia F,Venturoli N,Morselli-Labate AM,Rasciti L,Bolondi L.Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes:role of insulin resistance.Gut 2004; 53:1020-1023
-
9[9]Hamaguchi M,Kojima T,Takeda N,Nakagawa T,Taniguchi H,Fujii K,Omatsu T,Nakajima T,Sarui H,Shimazaki M,Kato T,Okuda J,Ida K.The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.Ann Intern Med 2005; 143:722-778
-
10[10]Isomaa B,Almgren P,Tuomi T,Forsen B,Lahti K,Nissen M,Taskinen MR,Groop L.Cardiovascular morbidity and mortality associated with the metabolic syndrome.Diabetes Care 2001; 24:683-689
共引文献61
-
1郑真,潘雪飞,江立红,梁谷米.军事飞行人员非酒精性脂肪肝影响因素的分析[J].中华航空航天医学杂志,2009,20(3):186-191. 被引量:8
-
2Yusuf Yilmaz.Liver function tests: Association with cardiovascular outcomes[J].World Journal of Hepatology,2010,2(4):143-145. 被引量:1
-
3田堃,赵宝珍.非乙醇性脂肪性肝病的流行病学及发病机制[J].医学综述,2008,14(6):856-858. 被引量:2
-
4周琦,范建高.非酒精性脂肪性肝病与冠心病的关系及相关研究进展[J].中国动脉硬化杂志,2008,16(8):669-672. 被引量:11
-
5左文革,王春平,薛兴存,李明泉,郭星.315例非酒精性脂肪性肝病的追踪观察与临床分析[J].中国医师进修杂志(内科版),2009,32(2):10-13.
-
6楚蓝,戴红.非酒精性脂肪肝及其与代谢综合征关系的研究进展[J].国外医学(卫生学分册),2009,36(6):383-385. 被引量:14
-
7黄群,陈小珠,黄健,徐平如,何剑琴,王晓玲,郑昌京,李俊达.非酒精性脂肪性肝病患者心脏舒张功能变化的研究[J].胃肠病学和肝病学杂志,2010,19(1):75-77. 被引量:9
-
8刘利蕊,傅君芬,梁黎,黄珂.肥胖儿童非酒精性脂肪肝病与心血管疾病的相关性[J].中国当代儿科杂志,2010,12(7):547-550. 被引量:2
-
9王晔,陆志刚,高美芳,周密,包玉倩,贾伟平.冠心病患者伴非酒精性脂肪性肝病的临床特征分析[J].中华内分泌代谢杂志,2010,26(7):541-544. 被引量:9
-
10黄健,黄群,陈小珠,周锋,陈小华,何剑琴.非酒精性脂肪性肝炎患者心脏舒张功能变化及其与肝功能的相关性研究[J].实用肝脏病杂志,2010,13(6):433-435. 被引量:2
-
1余飞龙,陈树荣,等.全胰腺脂肪变1例[J].中外医用放射技术,2001(10):64-64.
-
2张娟惠,蔡和利.复方丹参滴丸联合易善复治疗非酒精性脂肪肝45例[J].福建中医药,2011,42(4):24-25. 被引量:5
-
3王韶明,郑柏波,贾云杰,母凯萍.300例非酒精性脂肪性肝病临床分析[J].中国保健,2010(3):35-35.
-
4陈祎,厉有名.非酒精性脂肪性肝病与果糖[J].中华肝脏病杂志,2014,22(5):383-385. 被引量:7
-
5刘光伟,王春芳,扈晓宇,赵文霞.慢性丙肝相关性脂肪肝与瘦素及胰岛素抵抗的关系研究[J].西部医学,2011,23(12):2326-2327. 被引量:1
-
6施尧,李继强.药物性肝损害的病理[J].肝脏,2001,6(1):42-42. 被引量:8
-
7赵文霞.脂肪肝——不容忽视的疾病[J].中国中西医结合杂志,2007,27(4):295-295. 被引量:15
-
8韩加强,孟庆敏.脂肪肝的辨证论治[J].亚太传统医药,2007,3(2):62-62. 被引量:28
-
9瞿金涛,汪玫,汤宇,姚定康.非酒精性脂肪性肝病药物治疗的临床应用[J].肝脏,2010,15(2):135-137.
-
10闫丽辉,穆标,管乐,刘新宇,朱晓义,王少真.血红蛋白与2型糖尿病合并非酒精性脂肪性肝病的相关性[J].中华医学杂志,2016,96(34):2754-2756. 被引量:3